Comparative analysis of Gram's stain, PNA-FISH and Sepsityper with MALDI-TOF MS for the identification of yeast direct from positive blood cultures

Mycoses

Volumn 57, Issue 10, 2014, Pages 592-601

  Gorton, Rebecca L ^a,b   Ramnarain, P ^a   Barker, K ^c   Stone, N ^d   Rattenbury, S ^a   McHugh, T D ^b   Kibbler, C C ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Blood culture; Candida; Gram's stain; MALDI TOF; PNA FISH

Indexed keywords

FUNGAL RNA; PEPTIDE NUCLEIC ACID; RIBOSOME RNA; CRYSTAL VIOLET; GRAM'S STAIN; PHENAZINE DERIVATIVE;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD CULTURE; BRUKER SEPSITYPER; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA NEOFORMANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; FUNGUS CULTURE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PEPTIDE NUCLEIC ACID IN SITU HYBRIDISATION YEAST TRAFFIC LIGHT SYSTEM; PICHIA GUILLIERMONDII; SPECIES IDENTIFICATION; TURNAROUND TIME; BLOOD; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGEMIA; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES; STAINING; YEAST;

BLOOD; FUNGEMIA; GENTIAN VIOLET; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MYCOLOGICAL TYPING TECHNIQUES; PHENAZINES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STAINING AND LABELING; YEASTS;

EID: 84906817345     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12205     Document Type: Article

References (41)

1. Morgan J, Meltzer MI, Plikaytis BD et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005; 26: 540-7.
2. Tortorano AM, Peman J, Bernhardt H et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317-22.
3. Oeser C, Lamagni T. Heath PT, Sharland M, Ladhani S, The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000-2009. Pediatr Infect Dis J 2013; 32: 23-6.
4. Odds FC, Hanson MF, Davidson AD et al. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 2007; 56: 1066-75.
5. Arendrup MC, Bruun B, Christensen JJ et al. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 2011; 49: 325-34.
6. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998; 31: 327-32.
7. Schelenz S, Barnes RA, Kibbler CC, Jones BL, Denning DW. Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit. J Infect 2009; 58: 145-53.
8. Arendrup MC, Fuursted K, Gahrn-Hansen B et al. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect 2008; 14: 487-94.
9. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 2011; 38: 65-69.
10. Rocco TR, Reinert SE, Simms HH. Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance. Arch Surg 2000; 135: 160-5.
11. Kullberg BJ, Verweij PE, Akova M et al. European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect 2011; 17(Suppl. 5): 1-12. doi: 10.1111/j.1469-0691.2011.03615.x.
12. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49: 3640-5.
13. Buchaille L, Freydiere AM, Guinet R, Gille Y. Evaluation of six commercial systems for identification of medically important yeasts. Eur J Clin Microbiol Infect Dis 1998; 17: 479-88.
14. Willemsen M, Breynaert J, Lauwers S. Comparison of Auxacolor with API 20 C Aux in yeast identification. Clin Microbiol Infect 1997; 3: 369-75.
15. Bedini A, Venturelli C, Mussini C et al. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 2006; 12: 75-80.
16. Harrington A, McCourtney K, Nowowiejski D, Limaye A. Differentiation of Candida albicans from non-albicans yeast directly from blood cultures by Gram stain morphology. Eur J Clin Microbiol Infect Dis 2007; 26: 325-9.
17. Stender H. PNA FISH: an intelligent stain for rapid diagnosis of infectious diseases. Expert Rev Mol Diagn 2003; 3: 649-55.
18. Yan Y, He Y, Maier T et al. Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system. J Clin Microbiol 2011; 49: 2528-32.
19. Shepard JR, Addison RM, Alexander BD et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008; 46: 50-55.
20. Seng P, Drancourt M, Gouriet F et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009; 49: 543-51.
21. Ferreira L, Sanchez-Juanes F, Porras-Guerra I et al. Microorganisms direct identification from blood culture by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2011; 17: 546-51.
22. Moussaoui W, Jaulhac B, Hoffmann AM et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identifies 90% of bacteria directly from blood culture vials. Clin Microbiol Infect 2010; 16: 1631-8.
23. White TJ, Bruns T, Lee S, Taylor JW. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds), PCR Protocols: a Guide to Methods and Applications. New York, NY: Academic Press, Inc., 1990: 315-22.
24. Jenkins C, Ling CL, Ciesielczuk HL et al. Detection and identification of bacteria in clinical samples by 16S rRNA gene sequencing: comparison of two different approaches in clinical practice. J Med Microbiol 2012; 61: 483-8.
25. Marklein G, Josten M, Klanke U et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 2009; 47: 2912-17.
26. Mcbride WJH. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th edn. Sexual Health 2010; 7: 218.
27. Farina C, Perin S, Andreoni S et al. Evaluation of the peptide nucleic acid fluorescence in situ hybridisation technology for yeast identification directly from positive blood cultures: an Italian experience. Mycoses 2012; 55: 388-92.
28. Hall L, Le Febre KM, Deml SM, Wohlfiel SL, Wengenack NL. Evaluation of the Yeast Traffic Light PNA FISH probes for identification of Candida species from positive blood cultures. J Clin Microbiol 2012; 50: 1446-8.
29. Branda JA, Ferraro MJ, Kratz A. Sensitivity of peripheral blood smear review for the diagnosis of Candida fungemia. Arch Pathol Lab Med 2007; 131: 97-101.
30. Leli C, Cenci E, Cardaccia A et al. Rapid identification of bacterial and fungal pathogens from positive blood cultures by MALDI-TOF MS. Int J Med Microbiol 2013; 303: 205-9.
31. Jamal W, Saleem R, Rotimi VO. Rapid identification of pathogens directly from blood culture bottles by Bruker matrix-assisted laser desorption laser ionization-time of flight mass spectrometry versus routine methods. Diagn Microbiol Infect Dis 2013; 76: 404-8.
32. Spanu T, Posteraro B, Fiori B et al. Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol 2012; 50: 176-9.
33. Ferroni A, Suarez S, Beretti JL et al. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010; 48: 1542-8.
34. Pulcrano G, Iula DV, Vollaro A et al. Rapid and reliable MALDI-TOF mass spectrometry identification of Candida non-albicans isolates from bloodstream infections. J Microbiol Methods 2013; 94: 262-6.
35. Schubert S, Weinert K, Wagner C et al. Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. J Mol Diagn 2011; 13: 701-6.
36. Drancourt M. Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review. Clin Microbiol Infect 2010; 16: 1620-5.
37. Barker K, Gorton RL, Stone NR, Rattenbury S, Kibbler C. Investigating the critical steps in the identification of yeasts from blood cultures using MALDI-TOF. Mycoses 2013; 54: 75-76.
38. Horvath LL, Hospenthal DR, Murray CK, Dooley DP. Detection of simulated candidemia by the BACTEC 9240 system with plus aerobic/F and anaerobic/F blood culture bottles. J Clin Microbiol 2003; 41: 4714-17.
39. Alexander BD, Ashley ED, Reller LB, Reed SD. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis 2006; 54: 277-82.
40. Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm 2012; 69: 1910-14.
41. Stone NR, Gorton RL, Barker K, Ramnarain P, Kibbler CC. Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact. J Clin Microbiol 2013; 51: 1301-2.